Hypersensitivity reaction to pegylated liposomal doxorubicin administration for Mullerian carcinoma in Japanese women-Reference-Cited by-同舟云学术

Hypersensitivity reaction to pegylated liposomal doxorubicin administration for Mullerian carcinoma in Japanese women

Published:2021-01-27 Issue:4 Volume:47 Page:1544-1548
ISSN:1341-8076
Container-title:Journal of Obstetrics and Gynaecology Research
language:en
Short-container-title:J. Obstet. Gynaecol. Res.

Author:

Yamaguchi Shinichiro¹,Yahata Hideaki¹,Okugawa Kaoru¹,Kodama Keisuke¹,Yagi Hiroshi¹,Yasunaga Masafumi¹,Ohgami Tatsuhiro¹,Onoyama Ichiro¹,Asanoma Kazuo¹,Kato Kiyoko¹

Affiliation:

1. Department of Obstetrics and Gynecology, Graduate School of Medical Sciences Kyushu University Fukuoka Japan

Publisher

Wiley

Subject

Obstetrics and Gynecology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jog.14680

Reference12 articles.

1. Pharmacokinetics of Pegylated Liposomal Doxorubicin

2. Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): possible role in hypersensitivity reactions

3. Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: Analysis from the GCIG CALYPSO relapsing ovarian cancer trial

4. Prophylactic effect of pemirolast, an antiallergic agent, against hypersensitivity reactions to paclitaxel in patients with ovarian cancer

5. Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers of PEGylated Liposomal Doxorubicin-Induced Hypersensitivity Reaction in Breast Cancer Patients Based on Metabolomics;Frontiers in Pharmacology;2022-04-21

2. Doxorubicin-liposomal;Reactions Weekly;2021-05